Reliance Life Sciences is developing
a range of biopharmaceutical products
in the categories of:
- Blood Plasma proteins
- Biogeneric Recombinant proteins
- Novel Recombinant proteins
- Humanised Monoclonal antibodies
- siRNA molecules
There are fifteen biopharmaceuticals
in various stages of development.
Reliance Life Sciences currently markets
the following biopharmaceutical products:
- ReliSeal (fibrin sealants)
- AlbuRel (albumin)
- ImmunoRel (immunoglobulin)
- HemoRel (anti-hemophilic factor)
- ReliPlasma (virus inactivated plasma).
